Oroxin B|cas 114482-86-9|Supplied by DC Chem

Cas No.:	114482-86-9
SMILES:	O=C1C=C(C2=CC=CC=C2)OC3=CC(O[C@H]4[C@@H]([C@H]([C@@H]([C@@H](CO[C@H]5[C@@H]([C@H]([C@@H]([C@@H](CO)O5)O)O)O)O4)O)O)O)=C(O)C(O)=C13
Formula:	C₂₇H₃₀O₁₅
M.Wt:	594.52
Purity:	>98%, Standard References Grade
Sotrage:	4°C for 1 year, -20°C for more than 2 years

Description:

For the detailed information of Oroxin B, the solubility of Oroxin B in water, the solubility of Oroxin B in DMSO, the solubility of Oroxin B in PBS buffer, the animal experiment（test） (test) of Oroxin B, the cell expriment (test) of Oroxin B, the in vivo, in vitro and clinical trial test of Oroxin B, the EC50, IC50,and Affinity of Oroxin B,, please contact DC Chemicals.

MSDS

COA

LOT NO.	DOWNLOAD

2018-0101

Cat. No.	Product name	Field of application
DCC-003	Vincristine	>98%,Standard References
DCZ-289	songorine	purity >98%,Standard References
DCZ-286	8-GERANOPSORALEN	purity >98%,Standard References
DCZ-290	Isobavachin	purity >98%,Standard References
DCZ-292	TECTOCHRYSIN	purity >98%,Standard References
DCZ-291	isorhapontigenin	purity >98%,Standard References
DCZ-287	Protopine	purity >98%,Standard References
DC8874	7-TACA	Impurity D of Cefoperazone
DCQ-033	fraxin	Fraxin is a coumarin glycoside that has been found in Fraxinus and has anti-inflammatory activity.
DC23085	Dihydrocapsaicin	Dihydrocapsaicin, a potential inducer of autophagy, has cytotoxic activity. It has anti-atherogenic activity, can reduce the susceptibility of low-density lipoprotein (LDL) to oxidation. Dihydrocapsaicin treatment depletes peptidergic nerve fibers of subs